Clinical Trials

Colorectal Cancer, Hereditary Nonpolyposis, Type 6, Carcinoma, Colorectal Neoplasms

NCT03370276 2026-03-10

Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

95 enrolled 15 charts

Squamous Cell Carcinoma of Head and Neck, Neoplasms, Squamous Cell

NCT06412198 2026-03-06

A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations

31 enrolled

Phase 1/2 Active not recruiting

Colorectal Neoplasms

NCT04616183 2025-12-23

LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer

46 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT05956821 2025-12-08

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

Phase 1/2 Active not recruiting

20 enrolled

CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Oligodendroglioma

NCT04017650 2025-11-20

Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer

38 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Disease Progression

NCT05200442 2025-11-05

A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer

53 enrolled

Colorectal Neoplasms

NCT07204574 2025-10-02

The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer

40 enrolled

CRC

NCT07012954 2025-06-24

ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC

64 enrolled

Colorectal Cancer Metastatic

NCT03428958 2025-04-23

A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment

111 enrolled 22 charts

Colonic Neoplasms, Colorectal Neoplasms

NCT06379399 2024-04-23

Trifluridine/Tipiracil Combined With Cetuximab in the Treatment of Third-line and Above RAS/BRAF Wild-type mCRC

26 enrolled

Colorectal Cancer Metastatic

NCT02101034 2023-12-21

PD 0332991 and Cetuximab in Patients With Incurable SCCHN

96 enrolled 17 charts

Squamous Cell Carcinoma of Head and Neck

NCT01004731 2023-05-25

Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung Cancer

7 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04790448 2023-02-15

Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal Cancer

37 enrolled

Colorectal Cancer Metastatic

NCT02713373 2022-10-06

Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery

45 enrolled 14 charts

Colorectal Neoplasms

NCT01884740 2022-08-09

Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22

13 enrolled 6 charts

CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

NCT00660218 2021-11-08

A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer

53 enrolled

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT01077986 2021-04-21

Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer

35 enrolled

Pancreatic Neoplasms

NCT02117466 2021-04-14

IMPACT-CRC

85 enrolled

Colorectal Neoplasms

NCT02822482 2021-03-29

COPAN-ORL06

11 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02054442 2021-03-12

COMMENCE

52 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT00851877 2020-08-21

Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer

37 enrolled 9 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT02855086 2020-03-31

Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery

3 enrolled 7 charts

CNS

Brain Neoplasms, Glioma

NCT02318901 2019-10-21

PembroMab

16 enrolled 6 charts

BreastGastrointestinal

Breast Neoplasms, Esophageal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT02845856 2019-09-12

Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer

30 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00923299 2019-04-16

THERAPY

33 enrolled

Pancreatic Neoplasms

NCT02507154 2018-08-21

NKEXPHNC

31 enrolled

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Neoplasms

NCT01009346 2018-07-17

RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHN

9 enrolled 9 charts

Head and Neck Neoplasms

NCT00226941 2017-12-08

A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer

23 enrolled 18 charts

Colonic Neoplasms, Rectal Neoplasms

NCT03051906 2017-11-22

DUCRO-HN

69 enrolled

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00570674 2017-11-13

Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck

29 enrolled 13 charts

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Adenosquamous

NCT02298595 2017-11-13

Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma

Phase 1/2 Withdrawn

Carcinoma, Carcinoma, Squamous Cell, Oropharyngeal Neoplasms

NCT00704639 2017-07-12

Chemoradiation Treatment for Head and Neck Cancer

60 enrolled

Head and Neck Neoplasms

NCT00408499 2017-05-08

Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer

64 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00361244 2017-02-17

SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer

6 enrolled

Colorectal Neoplasms

NCT00216203 2016-09-29

Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer

36 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT00544362 2016-05-30

Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery

33 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01042028 2015-10-20

A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer

39 enrolled

Pancreatic Neoplasms

NCT00522665 2015-05-15

Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer

41 enrolled

Colorectal Neoplasms

NCT00815295 2014-12-08

Study of Sorafenib/Cetuximab in Head and Neck Cancer

31 enrolled 11 charts

Neoplasms, Squamous Cell

NCT01283334 2014-12-04

A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer

20 enrolled 8 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00425425 2014-05-01

Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer

43 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01712919 2014-03-24

Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)

61 enrolled

Nasopharyngeal Carcinoma

NCT01192087 2013-04-24

ACCEPT

49 enrolled

Carcinoma, Adenoid Cystic

NCT01611506 2013-01-09

Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric Cancer

1 enrolled

Stomach Neoplasms

NCT01760811 2013-01-04

CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENT

25 enrolled

Tumor-Agnostic

Carcinoma, Squamous Cell

NCT01015664 2012-12-17

Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

11 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT00714649 2012-11-14

CHIRON

34 enrolled

Head and Neck Neoplasms

NCT00445861 2012-06-11

Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

27 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01166035 2010-07-20

TEXO